KSC · 016580.KS
Whan In Pharm Co.,Ltd.
₩10,400-₩80 (-0.76%)
Whan In Pharm Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 14.33% below the high.
Loading market information…
KSC · 214390.KS · KRW
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Kyongbo Pharmaceutical Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 44.73% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Kyongbo Pharmaceutical Co., Ltd’s forward annual dividend is ₩50 per share, paid annual. The forward yield is 0.97% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Kyongbo Pharmaceutical Co., Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1987 and based in Asan, South Korea, Kyongbo Pharmaceutical Co., Ltd is a key player in the South Korean pharmaceutical market, primarily focusing on the production and distribution of active pharmaceutical ingredients (APIs). Its API offerings span general, cephalosporin, and anti-cancer categories. Beyond APIs, the company also supplies a range of finished pharmaceutical products, including prescription medications for anesthetic, cardiovascular, and digestive uses, as well as antibiotics, alongside its over-the-counter (OTC) drug portfolio. Kyongbo Pharmaceutical extends its reach internationally, exporting its goods to 30 countries worldwide. The company officially adopted its current name, Kyongbo Pharmaceutical Co., Ltd, in March 2002, having previously been known as Kyongbo Chemical Co. Ltd.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:49 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩10,400-₩80 (-0.76%)
Whan In Pharm Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 14.33% below the high.
₩10,510-₩80 (-0.76%)
JW Lifescience Corporation’s quoted price sits in the lower half of its reported 52-week range, 32.54% below the high.
₩21,150-₩650 (-2.98%)
Ilsung Is Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.82% below the high.
₩5,100-₩60 (-1.16%)
Dongwha Pharm.Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 32.54% below the high.
₩1,203-₩27 (-2.2%)
SAMSUNG PHARM. Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.15% below the high.
₩8,210-₩170 (-2.03%)
HANDOK Inc.’s quoted price sits in the lower half of its reported 52-week range, 32.43% below the high.
₩6,720-₩60 (-0.88%)
Jeil Pharma Holdings Inc’s quoted price sits in the lower half of its reported 52-week range, 31.78% below the high.
₩12,330-₩20 (-0.16%)
CKD Bio Corp.’s quoted price sits in the lower half of its reported 52-week range, 50.48% below the high.
